BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34327606)

  • 1. Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats.
    Godoy-Lugo JA; Thorwald MA; Hui DY; Nishiyama A; Nakano D; Soñanez-Organis JG; Ortiz RM
    Endocrine; 2022 Jan; 75(1):92-107. PubMed ID: 34327606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved lipogenesis gene expression in liver is associated with elevated plasma angiotensin 1-7 after AT1 receptor blockade in insulin-resistant OLETF rats.
    Godoy-Lugo JA; Mendez DA; Rodriguez R; Nishiyama A; Nakano D; Soñanez-Organis JG; Ortiz RM
    Mol Cell Endocrinol; 2022 Sep; 555():111729. PubMed ID: 35921918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic AT
    Rodriguez R; Lee AY; Godoy-Lugo JA; Martinez B; Ohsaki H; Nakano D; Parkes DG; Nishiyama A; Vázquez-Medina JP; Ortiz RM
    Am J Physiol Endocrinol Metab; 2021 Nov; 321(5):E714-E727. PubMed ID: 34658252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats.
    Rodriguez R; Minas JN; Vazquez-Medina JP; Nakano D; Parkes DG; Nishiyama A; Ortiz RM
    J Endocrinol; 2018 Jun; 237(3):271-284. PubMed ID: 29643115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome.
    Rodriguez R; Viscarra JA; Minas JN; Nakano D; Nishiyama A; Ortiz RM
    Endocrinology; 2012 Apr; 153(4):1684-95. PubMed ID: 22355070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Increases Hepatic Mitochondrial Antioxidant Enzyme Activities in Insulin Resistant Rats Following Chronic Angiotensin Receptor Blockade.
    Godoy-Lugo JA; Thorwald MA; Mendez DA; Rodriguez R; Nakano D; Nishiyama A; Ortiz RM
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin receptor and tumor necrosis factor-α activation contributes to glucose intolerance independent of systolic blood pressure in obese rats.
    Rodriguez R; Lee A; Mathis KW; Broome HJ; Thorwald M; Martinez B; Nakano D; Nishiyama A; Ryan MJ; Ortiz RM
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1081-F1090. PubMed ID: 29993275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats.
    Montez P; Vázquez-Medina JP; Rodríguez R; Thorwald MA; Viscarra JA; Lam L; Peti-Peterdi J; Nakano D; Nishiyama A; Ortiz RM
    Endocrinology; 2012 Dec; 153(12):5746-59. PubMed ID: 23087176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous angiotensin receptor blockade and glucagon-like peptide-1 receptor activation ameliorate albuminuria in obese insulin-resistant rats.
    Rodriguez R; Escobedo B; Lee AY; Thorwald M; Godoy-Lugo JA; Nakano D; Nishiyama A; Parkes DG; Ortiz RM
    Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):422-431. PubMed ID: 31675433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats.
    Vázquez-Medina JP; Popovich I; Thorwald MA; Viscarra JA; Rodriguez R; Sonanez-Organis JG; Lam L; Peti-Peterdi J; Nakano D; Nishiyama A; Ortiz RM
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H599-607. PubMed ID: 23771688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats.
    Thorwald M; Rodriguez R; Lee A; Martinez B; Peti-Peterdi J; Nakano D; Nishiyama A; Ortiz RM
    Redox Biol; 2018 Apr; 14():371-378. PubMed ID: 29049981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats.
    Rodriguez-Ortiz CJ; Thorwald MA; Rodriguez R; Mejias-Ortega M; Kieu Z; Maitra N; Hawkins C; Valenzuela J; Peng M; Nishiyama A; Ortiz RM; Kitazawa M
    Clin Exp Pharmacol Physiol; 2023 Mar; 50(3):228-237. PubMed ID: 36398458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats.
    Rodriguez R; Moreno M; Lee AY; Godoy-Lugo JA; Nakano D; Nishiyama A; Parkes D; Awayda MS; Ortiz RM
    Hypertens Res; 2018 Oct; 41(10):798-808. PubMed ID: 29985448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2-related gene expression is impaired during a glucose challenge in type II diabetic rat hearts.
    Thorwald MA; Godoy-Lugo JA; Rodriguez GJ; Rodriguez MA; Jamal M; Kinoshita H; Nakano D; Nishiyama A; Forman HJ; Ortiz RM
    Free Radic Biol Med; 2019 Jan; 130():306-317. PubMed ID: 30316779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model.
    Shiba Y; Yamasaki Y; Kubota M; Matsuhisa M; Tomita T; Nakahara I; Morishima T; Kawamori R; Hori M
    Metabolism; 1998 Aug; 47(8):908-14. PubMed ID: 9711984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.
    Ishizaka N; Hongo M; Matsuzaki G; Furuta K; Saito K; Sakurai R; Sakamoto A; Koike K; Nagai R
    Hypertens Res; 2010 Mar; 33(3):263-8. PubMed ID: 20057486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.
    Kawabeta K; Hase-Tamaru S; Yuasa M; Suruga K; Sugano M; Koba K
    J Oleo Sci; 2019 Apr; 68(4):339-350. PubMed ID: 30867392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.
    Cho IJ; Oh DH; Yoo J; Hwang YC; Ahn KJ; Chung HY; Jeong SW; Moon JY; Lee SH; Lim SJ; Jeong IK
    Sci Rep; 2021 May; 11(1):9894. PubMed ID: 33972568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.